News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Valeant Pharmaceuticals International Reports First Quarter 2014 Financial Results
May 8, 2014
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LAVAL, Quebec, May 8, 2014 /PRNewswire/ --
•2014 First Quarter Total Revenue $1.9 billion; an increase of 77% over the prior year
?Exceeded our expectations
Help employers find you! Check out all the
jobs
and
post your resume
.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Valeant Pharmaceuticals International
MORE ON THIS TOPIC
Layoff Tracker
Mythic Therapeutics Runs Out of Options, Shuts Down Only Trial
December 17, 2025
·
96 min read
·
BioSpace Editorial Staff
Startups
Addition Debuts With $100M to Advance One-Time Therapies for Rare, Chronic Diseases
December 17, 2025
·
1 min read
·
Tristan Manalac
Vaccines
Pfizer CEO Blasts HHS’ Anti-Vaccine Policies as Revenue Outlook Dims
December 16, 2025
·
3 min read
·
Annalee Armstrong
Venture capital
Ambros Launches With $125M To Bring Italian Non-Opioid Pain Drug to America
December 16, 2025
·
1 min read
·
Annalee Armstrong